Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Colorectal Cancer Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 99

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Colorectal Cancer Market Professional Survey Report By Manufacturers, Key Regions, Product and Application 2018 - 2025

Oct-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 99 | Format : PDF

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.
In 2017, the global Colorectal Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global Colorectal Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Colorectal Cancer development in United States, Europe and China.

The key players covered in this study
    Roche
    Debiopharm
    Merck Kgaa
    Vaccinogen
    Aeterna Zentaris
    Keryx
    Spectrum Pharmaceuticals
    Mologen
    Amgen
    Bayer Healthcare

Market segment by Type, the product can be split into
    Macroscopy
    Microscopy
    Immunochemistry
    Staging
    Tumor Budding

Market segment by Application, split into
    Hospitals and Clicnics
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Colorectal Cancer status, future forecast, growth opportunity, key market and key players.
    To present the Colorectal Cancer development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Colorectal Cancer are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
<pre>Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Colorectal Cancer Market Size Growth Rate by Type (2013-2025) 1.4.2 Macroscopy 1.4.3 Microscopy 1.4.4 Immunochemistry 1.4.5 Staging 1.4.6 Tumor Budding 1.5 Market by Application 1.5.1 Global Colorectal Cancer Market Share by Application (2013-2025) 1.5.2 Hospitals and Clicnics 1.5.3 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Colorectal Cancer Market Size 2.2 Colorectal Cancer Growth Trends by Regions 2.2.1 Colorectal Cancer Market Size by Regions (2013-2025) 2.2.2 Colorectal Cancer Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Colorectal Cancer Market Size by Manufacturers 3.1.1 Global Colorectal Cancer Revenue by Manufacturers (2013-2018) 3.1.2 Global Colorectal Cancer Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Colorectal Cancer Market Concentration Ratio (CR5 and HHI) 3.2 Colorectal Cancer Key Players Head office and Area Served 3.3 Key Players Colorectal Cancer Product/Solution/Service 3.4 Date of Enter into Colorectal Cancer Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Colorectal Cancer Market Size by Type (2013-2018) 4.2 Global Colorectal Cancer Market Size by Application (2013-2018) 5 United States 5.1 United States Colorectal Cancer Market Size (2013-2018) 5.2 Colorectal Cancer Key Players in United States 5.3 United States Colorectal Cancer Market Size by Type 5.4 United States Colorectal Cancer Market Size by Application 6 Europe 6.1 Europe Colorectal Cancer Market Size (2013-2018) 6.2 Colorectal Cancer Key Players in Europe 6.3 Europe Colorectal Cancer Market Size by Type 6.4 Europe Colorectal Cancer Market Size by Application 7 China 7.1 China Colorectal Cancer Market Size (2013-2018) 7.2 Colorectal Cancer Key Players in China 7.3 China Colorectal Cancer Market Size by Type 7.4 China Colorectal Cancer Market Size by Application 8 Japan 8.1 Japan Colorectal Cancer Market Size (2013-2018) 8.2 Colorectal Cancer Key Players in Japan 8.3 Japan Colorectal Cancer Market Size by Type 8.4 Japan Colorectal Cancer Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Colorectal Cancer Market Size (2013-2018) 9.2 Colorectal Cancer Key Players in Southeast Asia 9.3 Southeast Asia Colorectal Cancer Market Size by Type 9.4 Southeast Asia Colorectal Cancer Market Size by Application 10 India 10.1 India Colorectal Cancer Market Size (2013-2018) 10.2 Colorectal Cancer Key Players in India 10.3 India Colorectal Cancer Market Size by Type 10.4 India Colorectal Cancer Market Size by Application 11 Central & South America 11.1 Central & South America Colorectal Cancer Market Size (2013-2018) 11.2 Colorectal Cancer Key Players in Central & South America 11.3 Central & South America Colorectal Cancer Market Size by Type 11.4 Central & South America Colorectal Cancer Market Size by Application 12 International Players Profiles 12.1 Roche 12.1.1 Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 Colorectal Cancer Introduction 12.1.4 Roche Revenue in Colorectal Cancer Business (2013-2018) 12.1.5 Roche Recent Development 12.2 Debiopharm 12.2.1 Debiopharm Company Details 12.2.2 Company Description and Business Overview 12.2.3 Colorectal Cancer Introduction 12.2.4 Debiopharm Revenue in Colorectal Cancer Business (2013-2018) 12.2.5 Debiopharm Recent Development 12.3 Merck Kgaa 12.3.1 Merck Kgaa Company Details 12.3.2 Company Description and Business Overview 12.3.3 Colorectal Cancer Introduction 12.3.4 Merck Kgaa Revenue in Colorectal Cancer Business (2013-2018) 12.3.5 Merck Kgaa Recent Development 12.4 Vaccinogen 12.4.1 Vaccinogen Company Details 12.4.2 Company Description and Business Overview 12.4.3 Colorectal Cancer Introduction 12.4.4 Vaccinogen Revenue in Colorectal Cancer Business (2013-2018) 12.4.5 Vaccinogen Recent Development 12.5 Aeterna Zentaris 12.5.1 Aeterna Zentaris Company Details 12.5.2 Company Description and Business Overview 12.5.3 Colorectal Cancer Introduction 12.5.4 Aeterna Zentaris Revenue in Colorectal Cancer Business (2013-2018) 12.5.5 Aeterna Zentaris Recent Development 12.6 Keryx 12.6.1 Keryx Company Details 12.6.2 Company Description and Business Overview 12.6.3 Colorectal Cancer Introduction 12.6.4 Keryx Revenue in Colorectal Cancer Business (2013-2018) 12.6.5 Keryx Recent Development 12.7 Spectrum Pharmaceuticals 12.7.1 Spectrum Pharmaceuticals Company Details 12.7.2 Company Description and Business Overview 12.7.3 Colorectal Cancer Introduction 12.7.4 Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2013-2018) 12.7.5 Spectrum Pharmaceuticals Recent Development 12.8 Mologen 12.8.1 Mologen Company Details 12.8.2 Company Description and Business Overview 12.8.3 Colorectal Cancer Introduction 12.8.4 Mologen Revenue in Colorectal Cancer Business (2013-2018) 12.8.5 Mologen Recent Development 12.9 Amgen 12.9.1 Amgen Company Details 12.9.2 Company Description and Business Overview 12.9.3 Colorectal Cancer Introduction 12.9.4 Amgen Revenue in Colorectal Cancer Business (2013-2018) 12.9.5 Amgen Recent Development 12.10 Bayer Healthcare 12.10.1 Bayer Healthcare Company Details 12.10.2 Company Description and Business Overview 12.10.3 Colorectal Cancer Introduction 12.10.4 Bayer Healthcare Revenue in Colorectal Cancer Business (2013-2018) 12.10.5 Bayer Healthcare Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details</pre>


 Latest Research Reports